Difference between revisions of "Part:BBa K2842669"
(`) |
|||
Line 4: | Line 4: | ||
<p> | <p> | ||
This DNA construct encodes a C terminal segment of the AceL-TerL intein fused to the N terminus of a mScarlet reporter protein with a C terminal StrepTag for purification. The AceL-TerL intein acts as a protein ligase that forms a peptide bond between this protein and another protein bound to a complementary split intein, during this process the intein splices itself out of protein and is not present in the end fusion protein. This construct is a modular platform for the creation of split intein fusion proteins through the SapI restriction sites located immediately upstream and downstream of the mScarlet reporter. BBa_K2832680 was designed to be used in conjunction with this construct as it contains the corresponding N terminal intein segment to enable intein trans-splicing. | This DNA construct encodes a C terminal segment of the AceL-TerL intein fused to the N terminus of a mScarlet reporter protein with a C terminal StrepTag for purification. The AceL-TerL intein acts as a protein ligase that forms a peptide bond between this protein and another protein bound to a complementary split intein, during this process the intein splices itself out of protein and is not present in the end fusion protein. This construct is a modular platform for the creation of split intein fusion proteins through the SapI restriction sites located immediately upstream and downstream of the mScarlet reporter. BBa_K2832680 was designed to be used in conjunction with this construct as it contains the corresponding N terminal intein segment to enable intein trans-splicing. | ||
+ | |||
+ | </p> | ||
+ | |||
+ | <p> | ||
+ | We measured the expression of Intein Passenger with a BMG plate reader by analysis of it's fluorescence at varying IPTG concentrations. We found on this that between 400 uM and 800 uM IPTG induction had little effect on expression or on cell growth rate (Fig1A,Fig1B). | ||
+ | |||
+ | We also tested the modularity of the construct by cloning in two new sequences to create the biobricks "NikR" and "ER" which can have been sequenced to confirm the sucessful assembly. This can also be seen in the analytic digest in Figure 2. | ||
+ | |||
+ | |||
+ | |||
</p> | </p> | ||
[[File:T--UCL--IP_IPTG_Variations.png|400px|thumb|right| | [[File:T--UCL--IP_IPTG_Variations.png|400px|thumb|right| | ||
<center>'''Figure 1: Expression of IP at varying IPTG concentrations'''</center> | <center>'''Figure 1: Expression of IP at varying IPTG concentrations'''</center> | ||
− | + | ||
Initial experiments suggested that 400 uM of IPTG was optimal for expression(data not shown). A plate reader was used to examine the region of IPTG concentrations around 400 uM | Initial experiments suggested that 400 uM of IPTG was optimal for expression(data not shown). A plate reader was used to examine the region of IPTG concentrations around 400 uM | ||
</p> | </p> |
Revision as of 18:23, 16 October 2018
mScarlet reporter with TerL-C intein on the N terminus
This DNA construct encodes a C terminal segment of the AceL-TerL intein fused to the N terminus of a mScarlet reporter protein with a C terminal StrepTag for purification. The AceL-TerL intein acts as a protein ligase that forms a peptide bond between this protein and another protein bound to a complementary split intein, during this process the intein splices itself out of protein and is not present in the end fusion protein. This construct is a modular platform for the creation of split intein fusion proteins through the SapI restriction sites located immediately upstream and downstream of the mScarlet reporter. BBa_K2832680 was designed to be used in conjunction with this construct as it contains the corresponding N terminal intein segment to enable intein trans-splicing.
We measured the expression of Intein Passenger with a BMG plate reader by analysis of it's fluorescence at varying IPTG concentrations. We found on this that between 400 uM and 800 uM IPTG induction had little effect on expression or on cell growth rate (Fig1A,Fig1B). We also tested the modularity of the construct by cloning in two new sequences to create the biobricks "NikR" and "ER" which can have been sequenced to confirm the sucessful assembly. This can also be seen in the analytic digest in Figure 2.
-
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12INCOMPATIBLE WITH RFC[12]Illegal NotI site found at 941
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000INCOMPATIBLE WITH RFC[1000]Illegal BsaI site found at 1224
Illegal BsaI.rc site found at 28
Illegal SapI site found at 1130
Illegal SapI.rc site found at 419